Summary
This prediction ended on 14.12.24 with a price of €180.35. The prediction had a final performance of 12.05%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| UCB S.A. | -2.291% | -2.291% | 39.121% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
According to BiotechBee what are the pros and cons of UCB S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread UCB S.A. diskutieren
Buy mit Kursziel 210,0